美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SL Science Holding Ltd

1.51

-0.0100-0.66%

盘后：1.610.0982+6.50%16:29 EDT

成交量：2.12万

成交额：3.28万

市值：8.46亿

市盈率：-2.34

高：1.62

开：1.50

低：1.50

收：1.52

52周最高：14.50

52周最低：1.42

股本：5.60亿

流通股本：2.27亿

量比：0.37

换手率：0.01%

股息：- -

股息率：- -

每股收益(TTM):-0.6447

每股收益(LYR):-0.4532

净资产收益率：-25.62%

总资产收益率：-14.70%

市净率：178.76

市盈率(LYR):-3.33

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

SL Science披露GDT细胞外泌体新FDA药物主文件，平台监管基础进一步夯实

SL Science于2026年世界基础与临床药理学大会成功展示突破性脑癌疗法研究成果

SL Science Holding Limited向美国FDA提交针对胶质母细胞瘤的GDT细胞疗法孤儿药资格认定申请

异动解读 | 完成SPAC合并后市场情绪逆转，HORIZON SPACE ACQUISITION II Corp盘中暴涨229.18%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/SLBT"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLBT\",,,,,undefined,":{"symbol":"SLBT","market":"US","secType":"STK","nameCN":"SL Science Holding Ltd","latestPrice":1.51,"timestamp":1791576000000,"preClose":1.52,"halted":0,"volume":21236,"hourTrading":{"tag":"盘后","latestPrice":1.6082,"preClose":1.51,"latestTime":"16:29 EDT","volume":102,"amount":163.5281952,"timestamp":1791577747329,"change":0.0982,"changeRate":0.065033,"amplitude":0.065033},"delay":0,"changeRate":-0.006578947368421058,"floatShares":226857620,"shares":560000000,"eps":-0.644729,"marketStatus":"盘后交易","change":-0.01,"latestTime":"10-09 16:32:37 EDT","open":1.5,"high":1.62,"low":1.5,"amount":32824,"amplitude":0.078947,"askPrice":1.74,"askSize":100,"bidPrice":1.5,"bidSize":96362,"shortable":3,"etf":0,"ttmEps":-0.644729,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.52,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.52,"latestTime":"08:22 EDT","volume":150,"amount":228,"timestamp":1791548524725,"change":-0.02,"changeRate":-0.013158,"amplitude":0.019737},"postHourTrading":{"tag":"盘后","latestPrice":1.6082,"preClose":1.51,"latestTime":"16:29 EDT","volume":102,"amount":163.5281952,"timestamp":1791577747329,"change":0.0982,"changeRate":0.065033,"amplitude":0.065033},"volumeRatio":0.369688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLBT\",,,,,undefined,":{"symbol":"SLBT","floatShares":226857620,"roa":"-14.70%","roe":"-25.62%","lyrEps":-0.453239,"volumeRatio":0.369688,"shares":560000000,"dividePrice":0,"high":1.62,"amplitude":0.078947,"preClose":1.52,"low":1.5,"week52Low":1.42,"pbRate":"178.76","psRate":"258.59","week52High":14.5,"institutionHeld":0,"latestPrice":1.51,"committee":0.997927,"eps":-0.644729,"divideRate":0,"volume":21236,"delay":0,"ttmEps":-0.644729,"open":1.5,"prevYearClose":10.545,"prevWeekClose":1.57,"prevMonthClose":1.7,"prevQuarterClose":1.7,"fiveDayClose":1.57,"twentyDayClose":2.06,"sixtyDayClose":4.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLBT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLBT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLBT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SLBT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SLBT","date":"2026-10-08","current":-2.380845,"percent":0.862745,"low":-791.521742,"twenty":-638.000002,"median":-435.217393,"eighty":-370.906205,"high":-182.131353,"avg":-472.624701,"sd":154.948341,"marketCap":855552938},"quantilePoints":[{"date":"2026-07-31","current":-364.945192,"twenty":-373.627903,"median":-369.015213,"eighty":-360.061167,"marketCap":434771250},{"date":"2026-08-07","current":-370.371886,"twenty":-395.063345,"median":-373.085233,"eighty":-362.50318,"marketCap":441236250},{"date":"2026-08-14","current":-184.859913,"twenty":-376.612585,"median":-361.892676,"eighty":-183.768489,"marketCap":438003750},{"date":"2026-08-21","current":-648.043481,"twenty":-637.043481,"median":-373.085233,"eighty":-189.77132,"marketCap":1535462558},{"date":"2026-08-28","current":-631.30435,"twenty":-637.043481,"median":-398.862031,"eighty":-288.859314,"marketCap":1495801164},{"date":"2026-09-04","current":-753.260872,"twenty":-649.000003,"median":-621.739133,"eighty":-356.398148,"marketCap":1784762752},{"date":"2026-09-11","current":-502.173915,"twenty":-649.478263,"median":-624.130437,"eighty":-361.282173,"marketCap":1189841835},{"date":"2026-09-18","current":-447.173915,"twenty":-648.043481,"median":-498.586959,"eighty":-367.11587,"marketCap":1059525824},{"date":"2026-09-25","current":-373.04348,"twenty":-647.086959,"median":-456.739132,"eighty":-371.440524,"marketCap":883882506},{"date":"2026-10-02","current":-382.608697,"twenty":-642.782611,"median":-446.75976,"eighty":-373.060181,"marketCap":906546160},{"date":"2026-10-08","current":-361.086958,"twenty":-638.000002,"median":-435.217393,"eighty":-370.906205,"marketCap":855552938}],"updateTime":1791574969244},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SLBT\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1105965981","title":"SL Science披露GDT细胞外泌体新FDA药物主文件，平台监管基础进一步夯实","url":"https://stock-news.laohu8.com/highlight/detail?id=1105965981","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105965981?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 20:01","pubTimestamp":1787832086,"startTime":"0","endTime":"0","summary":"SL Science近日对外界公布了一项重要进展——该公司已为GDT细胞来源的外泌体提交了全新的美国食品药品监督管理局药物主文件。此举被视为其平台在监管合规层面迈出的又一步，为后续产业化进程提供了更为坚实的制度支撑。值得关注的是，这份新备案的药物主文件并非孤立动作。SL Science此番抢先完成相关备案，无疑为其在合规竞争中占得先机。随着监管框架的逐步完善，外泌体赛道或将迎来新一轮洗牌。SL Science的这一步，或许正是其谋篇布局的关键一环。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141470862","title":"SL Science于2026年世界基础与临床药理学大会成功展示突破性脑癌疗法研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1141470862","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141470862?lang=zh_cn&edition=fundamental","pubTime":"2026-07-17 20:04","pubTimestamp":1784289856,"startTime":"0","endTime":"0","summary":"SL Science宣布，在2026年世界基础与临床药理学大会上，其突破性脑癌疗法的研究已成功完成展示。该成果标志着公司在神经肿瘤治疗领域的创新探索取得了重要阶段性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLBT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119449177","title":"SL Science Holding Limited向美国FDA提交针对胶质母细胞瘤的GDT细胞疗法孤儿药资格认定申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1119449177","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119449177?lang=zh_cn&edition=fundamental","pubTime":"2026-07-10 20:02","pubTimestamp":1783684977,"startTime":"0","endTime":"0","summary":"SL Science Holding Limited已正式向美国食品药品监督管理局提交申请，为其针对胶质母细胞瘤的GDT细胞疗法寻求孤儿药资格认定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161290456","title":"异动解读 | 完成SPAC合并后市场情绪逆转，HORIZON SPACE ACQUISITION II Corp盘中暴涨229.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161290456","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161290456?lang=zh_cn&edition=fundamental","pubTime":"2026-06-16 23:03","pubTimestamp":1781622193,"startTime":"0","endTime":"0","summary":"HORIZON SPACE ACQUISITION II Corp  今日盘中股价大幅飙升，涨幅高达229.18%，市场表现极为抢眼。这一惊人的上涨行情，紧随该公司通过特殊目的收购公司方式完成与SL Science的业务合并之后。市场情绪在短时间内发生了剧烈切换，从前一交易日的恐慌性抛售迅速转为积极的买入行为，从而推动了股价实现显著的V型反弹。这反映出在SPAC上市过程中，市场正在对公司的估值进行激烈的重估和寻找新的平衡点。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SLBT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SLBT\",params:#limit:6,delay:false,,,undefined,":[]}}